explor
associ
epsteinbarr
viru
infect
childhood
pneumonia
studi
two
patient
whose
mononucleosislik
ill
accompani
pneumonia
virolog
serolog
evid
current
recent
eb
v
infect
analyz
sera
children
age
rang
month
year
pulmonari
infiltr
presenc
four
class
antibodi
ebi
antibodi
respons
consist
current
recent
eb
viru
infect
found
two
children
igm
antibodi
ebv
viral
antigen
titer
indic
current
infect
patient
antibodi
compon
earli
antigen
complex
suggesnng
recent
infect
fourfold
rise
drop
one
eb
vspecif
antibodi
class
note
eight
patient
within
day
follow
onset
clinic
ill
patient
clinic
featur
suggest
infecti
mononucleosi
eight
serolog
evid
current
recent
ebv
infect
also
clinic
serolog
evid
infect
anoth
pathogenbacteri
viral
mycoplasm
thu
childhood
pneumonia
eb
v
may
primari
coprimari
secondari
pathogen
may
reactiv
cours
infect
anoth
agent
possibl
suppress
immun
function
may
precipit
infect
organ
unit
state
least
children
becom
infect
epsteinbarr
viru
adolesc
case
infect
subclin
mild
go
unrecogn
occasion
infect
may
present
classic
infecti
mononucleosi
may
take
form
neurolog
hematolog
disord
isol
instanc
infant
serolog
evid
current
ebv
infect
respiratori
ill
bronchopneumonia
whether
ebv
etiolog
agent
case
unclear
primari
infect
accompani
unusu
ill
clinician
rare
consid
possibl
ebv
may
play
role
implic
ebv
infect
children
especi
sinc
heterophil
antibodi
usual
absent
necessari
measur
antibodi
varieti
ebvspecif
antigen
appear
abbrevi
use
ebv
epstein
barr
viru
vca
viral
capsid
antigen
ea
earli
antigen
crp
creactiv
protein
ebna
epsteinbarr
associ
nuclear
antigen
cf
complement
fixat
ig
immunoglobulin
disappear
certain
antibodi
characterist
time
sequenc
provid
evid
current
recent
infect
agent
isol
viru
blood
oropharyng
secret
provid
proof
presenc
infect
briefli
report
two
patient
infecti
mononucleosislik
ill
c
c
p
n
e
p
n
e
u
n
virolog
serolog
evid
current
recent
ebv
infect
serv
stimulu
studi
systemat
possibl
associ
ebv
infect
episod
childhood
p
n
e
u
n
therefor
analyz
virusspecif
serolog
respons
children
radiograph
evid
p
r
e
n
c
h
l
lung
infect
n
b
pattern
consist
current
recent
ebv
infect
f
u
n
children
patient
black
boy
present
fever
irrit
cough
chest
radiograph
reveal
right
upper
left
lower
lobe
infiltr
admiss
hospit
temperatur
patient
tachypn
posterior
cervic
adenopathi
note
white
blood
cell
count
slightli
elev
mark
mononuclear
celt
predomin
atyp
lymphocyt
result
monotest
wampol
laboratori
neg
subsequ
complet
blood
count
show
leukocytosi
mani
atyp
lymphocyt
right
upper
lobe
lesion
clear
within
three
day
left
lower
lobe
infiltr
persist
shift
locat
fever
subsid
patient
discharg
fifth
hospit
day
eb
viru
recov
peripher
blood
thirteenth
day
saliva
fourth
thirteenth
fiftyninth
day
follow
onset
patient
b
white
girl
develop
nausea
dizzi
headach
puffi
eye
sore
throat
cervic
adenopathi
conjunct
three
week
prior
admiss
one
week
later
heterophil
antibodi
test
posit
patient
began
complain
difficulti
breath
dysphagia
symptom
persist
chest
radiograph
taken
two
day
hospit
reveal
diffus
patchi
pneumonia
patient
improv
regimen
oral
dicloxacillin
admit
hospit
dehydr
cough
mild
respiratori
distress
posit
find
includ
temperatui
e
bilater
otiti
media
inject
tonsil
exud
coars
rhonchi
sign
consolid
lower
lung
field
slightli
enlarg
liver
white
blood
cell
count
left
shift
blood
ga
valu
reveal
arteri
oxygen
desatur
improv
mask
chest
radiograph
show
multipl
infiltr
fig
monotest
posit
ox
hemolysin
titer
hospit
cours
character
five
day
spike
fever
chest
radiograph
show
consolid
lower
lung
field
sever
lower
airway
obstruct
moder
restrict
defect
cultur
blood
urin
sputum
throat
neg
bacteri
pathogen
includ
mycobacterium
tuberculosi
titer
cold
agglutinin
mycoplasma
pneumonia
complement
fixat
titer
rose
antibiot
regimen
journal
pediatr
decemb
consist
oxacillin
erythromycin
mark
clinic
improv
began
twelveth
hospit
day
ebv
recov
peripher
blood
twentyseventh
day
saliva
twentyseventh
thirtysecond
day
sputum
thirtysecond
day
follow
onset
ill
virus
isol
either
patient
ebvspecif
serolog
data
patient
includ
tabl
ii
serolog
survey
juli
may
children
mean
age
month
rang
month
year
radiograph
evid
pneumonia
seen
emerg
room
yalenew
hospit
origin
studi
prospect
determin
valu
creactiv
protein
differenti
bacteri
viral
pneumonia
basi
clinic
laboratori
evalu
patient
assign
time
one
four
clinic
categori
tabl
present
investig
serum
avail
member
origin
group
mean
age
month
rang
month
year
pair
sera
avail
patient
singl
sera
acut
convalesc
convalesc
sera
collect
day
acut
specimen
serolog
test
acut
convalesc
sera
screen
dilut
presenc
igg
antibodi
eb
viral
capsid
antigen
serial
twofold
dilut
contain
antibodi
ebvvca
prepar
measur
precis
titer
oflgg
lgm
antibodi
vca
indirect
immunofluoresc
sera
absorb
iggcoat
latex
particl
posit
sera
also
test
antibodi
ebv
nuclear
antigen
method
anticompl
indirect
immunofluoresc
antibodi
diffus
restrict
compon
ebv
earli
antigen
complex
distinguish
two
ea
pattern
intracellular
fluoresc
pair
slide
bear
antigen
smear
fix
aceton
methanol
restrict
compon
disappear
follow
methanol
fixat
pair
sera
also
examin
cf
test
evid
recent
current
infect
respiratori
viru
pathogen
includ
adenovirus
respiratori
syncyti
viru
influenza
b
parainfluenza
virus
mycoplasma
pneurnonia
test
perform
laboratori
divis
connecticut
state
depart
health
sputum
throat
swab
materi
mix
rpmi
medium
supplement
fetal
calf
serum
antibiot
freezethaw
filter
sampl
mix
ficollhypaqu
separ
human
umbil
cord
lymphocyt
standard
microtit
plate
transform
assay
peripher
blood
sampl
examin
presenc
leukocyteassoci
viru
similar
fashion
z
transform
event
score
end
six
week
specimen
oropharyng
mate
r
rial
also
test
presenc
respiratori
virus
inocul
tissu
cultur
rhesu
monkey
kidney
human
placent
fibroblast
hep
vero
use
standard
techniqu
cultur
examin
everi
day
cytopath
effect
test
hemadsorpt
seven
nine
day
cultur
techniqu
inadequ
isol
coronavirus
legionella
pneumonia
tabl
ii
howev
sinc
lung
tissu
cultur
imposs
prove
ebv
agent
directli
respons
either
instanc
pneumonia
ebv
antibodi
pattern
children
pneumonia
serolog
studi
time
relationship
appear
rise
declin
variou
antibodi
primari
ebv
infect
shown
fig
patient
whose
sera
examin
antibodi
ebv
igg
antibodi
ebvvca
reflect
either
current
previou
infect
among
group
seroposit
individu
evid
current
recent
infect
present
tabl
ii
two
high
level
igm
antibodi
vca
indic
acut
infect
ebv
time
clinic
present
igm
antibodyposit
individu
group
pneumonia
unknown
etiolog
two
patient
no
vcaigm
titer
sinc
low
level
lgm
may
reflect
residu
antibodi
follow
acut
infect
confound
influenc
rheumatoid
factor
patient
place
recent
infect
probabl
group
patient
suggest
evid
current
recent
infect
antibodi
ebvinduc
earli
antigen
instanc
earli
antibodi
direct
exclus
primarili
restrict
compon
ea
complex
find
agre
previou
studi
primari
infect
children
ten
alreadi
antibodi
ebna
indic
probabl
first
seen
pneumonia
least
six
eight
week
follow
onset
ebv
infect
perhap
even
later
one
except
serum
contain
antiebna
antibodi
contain
igm
antibodi
ebv
patient
current
recent
infect
pair
sera
avail
eight
fourfold
rise
andor
fall
one
antibodi
class
demonstr
review
hospit
record
patient
serolog
evid
ebv
infect
reveal
unusu
unexpect
clinic
laboratori
featur
children
febril
one
elev
white
blood
cell
count
six
patient
atyp
lymphocyt
seen
blood
smear
number
one
patient
clinic
signific
cervic
lymphaden
one
exud
tonsil
radiograph
evid
hepat
enlarg
five
patient
one
also
mark
splenomegali
noth
specif
pulmonari
infiltr
predilect
lobe
either
lung
hilar
lymphadenopathi
observ
one
child
patient
infiltr
shift
locat
involv
success
perihilar
region
right
upper
right
lower
left
lower
lobe
result
studi
provid
evid
appar
associ
episod
childhood
antibodi
titer
express
reciproc
highest
serum
dilut
produc
posit
reaction
tcurrent
infect
high
titer
igm
antibodi
vca
without
antibodi
ea
absenc
antibodi
ebna
recent
infect
probabl
low
absent
igm
antibodi
vca
igg
antibodi
vca
ea
present
antibodi
ebna
absent
present
low
titer
appear
cours
infect
w
infect
possibl
igm
antibodi
vca
presenc
antibodi
ea
ebna
vca
lie
restrict
diffus
least
fourfold
differ
titer
aceton
methanol
fix
smear
princip
respons
consid
restrict
compon
presenc
diffus
react
antibodi
exclud
twofold
differ
titer
aceton
methanol
fix
smear
observ
princip
respons
consid
direct
diffus
compon
ea
complex
pneumonia
andcurr
recent
ebv
infect
associ
observ
previous
babi
bronchopneumonia
igm
antibodi
ebv
occasion
instanc
classic
im
complic
pneumon
recent
renal
allograft
recipi
whose
fever
pneumonia
found
associ
primari
ebv
infect
describ
present
group
subject
associ
ebv
pneumon
process
suspect
clinic
two
patient
whose
histori
provid
other
ill
milder
base
result
routin
laboratori
test
bacteri
mycoplasm
wellrecogn
viral
pathogen
believ
etiolog
agent
epsteinbarr
virusassoci
pneumonia
number
seri
patient
pneumonia
whose
sera
test
criteria
current
infect
met
two
individu
high
level
igm
antibodi
ebvvca
sinc
antibodi
transient
peak
three
four
week
acut
infect
fall
undetect
level
eight
week
safe
assum
pneumonia
episod
children
tempor
coincid
primari
ebv
infect
fifteen
patient
antibodi
compon
earli
antigen
complex
ten
also
antibodi
ebna
sinc
two
class
antibodi
gener
appear
convalesc
phase
infect
data
indic
patient
present
pneumonia
may
recov
recent
eb
viru
infect
find
similar
observ
made
group
ebvinfect
children
present
minor
complaint
compat
infecti
process
studi
patient
experienc
recent
rather
current
infect
ebv
time
clinic
present
clinic
classif
pat
ent
base
serolog
data
alon
criteria
placement
one
group
versu
anoth
somewhat
artifici
exampl
present
studi
evid
recent
infect
least
firm
patient
acut
phase
antibodi
found
sera
direct
ea
antibodi
sometim
found
diseas
state
appar
unrel
ebv
healthi
donor
surpris
number
present
seri
patient
pneumonia
serolog
evid
current
recent
ebv
infect
also
antibodi
rise
known
respiratori
pathogen
tabl
signific
dual
infect
clear
perhap
ebv
may
occasion
act
copathogen
altern
ebv
induc
state
temporari
immunosuppress
precipit
agranulocytosi
activ
lymphoid
cell
contain
latent
agent
may
actual
predispos
patient
anoth
infect
recent
studi
two
children
present
compel
virolog
serolog
evid
dual
infect
ebv
adenoviru
unpublish
data
addit
patient
recent
describ
develop
sever
mycoplasma
pneumonia
infect
complic
immunosuppress
induc
infecti
mononucleosisl
patient
b
appear
respond
similar
fashion
final
infect
anoth
respiratori
pathogen
may
reactiv
latent
ebv
induc
transitori
serolog
respons
earli
antigen
may
occur
patient
ebv
infect
possibl
recent
onset
antibodi
respons
earli
antigen
induc
human
herpesviru
system
cytomegaloviru
varicellazost
occur
patient
primari
infect
also
recurr
infect
seem
like
situat
may
similar
ebv
although
radiograph
find
specif
character
pneumon
infecti
mononucleosi
previou
report
emphas
hilar
lymphadenopathi
strandlik
densiti
parenchyma
rare
nodular
densiti
pleural
effus
roentgenograph
find
indistinguish
primari
atyp
pneumonia
includ
shift
infiltr
also
describ
none
patient
whose
sera
examin
hilar
lymph
node
enlarg
lobar
interstiti
infiltr
seen
suggest
unusu
etiolog
therefor
base
radiograph
serolog
data
entir
possibl
mani
patient
pneumonia
caus
classic
respiratori
pathogen
instanc
ebv
may
set
stage
definit
infect
may
reactiv
nonspecif
ebv
antibodi
respons
may
occur
sinc
limit
small
volum
sera
abl
screen
sampl
presenc
heterophil
antibodi
howev
number
investig
consist
shown
heterophil
respons
unusu
primari
ebv
infect
childhood
except
infect
present
form
infecti
mononucleosi
studi
reemphas
difficulti
accur
determin
caus
episod
pneumonia
order
ascrib
eb
viru
etiolog
role
pneumonia
childhood
extens
prospect
epidemiolog
virolog
studi
requir
evid
immunosuppress
patient
would
great
interest
sinc
would
help
explain
secondari
infect
seem
occur
clarifi
point
ebv
includ
among
pathogen
sought
bronchial
wash
pulmonari
tissu
patient
pneumonia
would
particularli
relev
studi
immunosuppress
individu
pneumonia
unknown
etiolog
grate
dr
georg
miller
jame
niederman
review
counsel
also
thank
dr
arthur
frank
help
col
ect
catalogu
serum
specimen
dr
paul
spivack
kenneth
robbin
anthoni
piccirillo
invit
us
see
patient
joyc
nepiarski
provid
excel
help
prepar
manuscript
